Categories: Financial Results

Apollo Hospitals announces Q1 FY19 results

New Delhi, August 12, 2018: Q1FY19 Standalone Revenues grew 16% to Rs.19,104 million compared to Rs.16,504 million in Q1FY18, aided by SAP growth of 20% and Healthcare services growth of 12% YoY. HC services growth of 12% YoY was led by new hospitals which reported 23% YoY Revenue growth while existing hospitals grew 10% YoY. EBITDA was at Rs.2,267 million in Q1FY19 as against Rs.1,734 million in Q1FY18 a YoY growth of 31%. PAT grew by 71% to Rs.602 million in Q1FY19.

The strategy around both services pricing as well as cost optimisation has delivered initial results. Healthcare Services EBITDA grew by 31% YoY to Rs. 1,849 million. Existing health care services EBITDA margins have improved from 20.4% last year to 21.6% in the current quarter. Apollo Hospitals stands committed to continue on this trajectory to further improve the margins to 23% over the next few quarters. Read more

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

2 days ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

3 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

3 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

4 days ago